ImageneBio, Inc.
IMA
$8.35
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.69% | 12.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.25% | -69.72% | |||
| Operating Income | -15.25% | 73.28% | |||
| Income Before Tax | -21.19% | 72.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.19% | 72.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.19% | 72.77% | |||
| EBIT | -15.25% | 73.28% | |||
| EBITDA | -23.94% | 72.56% | |||
| EPS Basic | 51.59% | 74.71% | |||
| Normalized Basic EPS | 49.90% | 81.11% | |||
| EPS Diluted | 51.59% | 74.71% | |||
| Normalized Diluted EPS | 49.90% | 81.11% | |||
| Average Basic Shares Outstanding | 141.88% | 43.76% | |||
| Average Diluted Shares Outstanding | 141.88% | 43.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||